Efficacy of Leech therapy in Ringworm
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: B359- Dermatophytosis, unspecified
- Registration Number
- CTRI/2019/06/019781
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically Diagnosed patient of Qooba (Tinea corporis and Tinea pedis only, as leech application will be more feasible to these sites)
Willing to participate in the study and follow the
instructions
Exclusion Criteria
Uncontrolled Diabetes mellitus
Bleeding disorder & anaemia
Acute infection & septicaemia
Patients on concomitant therapy
Immuno-compromised patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method KOH smear <br/ ><br>Erythema and Scaling will be graded on a 4 point scale (0 Absent, 1 Mild, 2 Moderate and 3 Severe) <br/ ><br>Pruritus will be assessed on 10 cm long Visual Analogue Scale (VAS). <br/ ><br>Photographs of the affected site in a fixed location and controlled illumination.Timepoint: At Baseline, on 21st day and on 35th day. <br/ ><br>Follow ups on 35th day in person and over phone on 45th, 60th and 90th day.
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil